-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QG+U3YkHmFLtZPVwYlV5PWuDfG03rBnMQ2VwLkF69Ntvntfg0KffmfSCknLtaWjR nNCtjqvAIJEpdgwuCWN+SA== 0000899243-01-501323.txt : 20010822 0000899243-01-501323.hdr.sgml : 20010822 ACCESSION NUMBER: 0000899243-01-501323 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20010731 ITEM INFORMATION: Other events FILED AS OF DATE: 20010821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RETRACTABLE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000946563 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 752599762 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16465 FILM NUMBER: 1720182 BUSINESS ADDRESS: STREET 1: 511 LOBO LANE CITY: LITTLE ELM STATE: TX ZIP: 75068-0009 BUSINESS PHONE: 9722941010 MAIL ADDRESS: STREET 1: 511 LOBO LANE CITY: LITTLE ELM STATE: TX ZIP: 75068-0009 8-K 1 d8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) July 31, 2001 ------------- Retractable Technologies, Inc. - -------------------------------------------------------------------------------- (Exact Name of Registrant as Specified in Charter) Texas 000-30885 75-2599762 - -------------------------------------------------------------------------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.)
511 Lobo Lane, Little Elm, Texas 75068-0009 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (972) 294-1010 -------------- None - -------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) ITEM 5 OTHER EVENTS On July 31, 2001, the Registrant issued a press release, a copy of which is attached to this Form 8-K as exhibit 99.1. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. DATE: August 20, 2001 RETRACTABLE TECHNOLOGIES, INC. (Registrant) By:/S/ Thomas J. Shaw ------------------------------------- THOMAS J. SHAW CHAIRMAN, PRESIDENT, AND CHIEF EXECUTIVE OFFICER INDEX TO EXHIBITS EXHIBIT NO. DESCRIPTION - ----------- ----------- 99.1 Press Release of Retractable Technologies, Inc. issued July 31, 2001 99.2 First Amendment to National Marketing and Distribution Agreement EX-99.1 3 dex991.txt PRESS RELEASE EXHIBIT 99.1 FOR IMMEDIATE RELEASE RETRACTABLE TECHNOLOGIES' VANISHPOINT(R) SAFETY SYRINGES TO BE INCLUDED IN ABBOTT LABORATORIES' HOSPITAL ANESTHESIA TRAYS Little Elm, Texas, July 31, 2001--Retractable Technologies, Inc. (AMEX; RVP), a leading maker of safety needle products, today announced that it had signed an agreement with Abbott Laboratories (NYSE; ABT) granting Abbott the exclusive right to place Retractable's VanishPoint(R) automated retraction syringes in its spinal and epidural anesthesia trays. Under the terms of the agreement, Abbott will use Retractable's 1cc and 3cc syringes in these trays, which Abbott markets to acute care hospitals in the United States. Abbott expects to begin shipping the trays to its customers in the fourth quarter of this year. The new marketing agreement represents an amendment to a five-year marketing and distribution pact Retractable signed with Abbott in May 2000, under which Abbott markets and distributes Retractable's syringes and blood collection devices to the acute care hospital market. Thomas J. Shaw, president and CEO of Retractable, said, "We're interested in every opportunity to get wider exposure for our innovative retractable needle technology and to generate hospital-wide demand for VanishPoint(R) products." Retractable's revolutionary safety needle products virtually eliminate health care workers' exposure to accidental needlestick injuries, which can result in HIV/AIDS, hepatitis B, hepatitis C and other potentially deadly bloodborne diseases. VanishPoint(R) devices use a patented friction ring mechanism that causes the contaminated needle to retract automatically from the patient into the barrel of the device. For more information on Retractable, visit our Web site at Vanishpoint.com. CONTACT: Retractable Technologies, Inc. Media Contact: Phillip L. Zweig, 212/490-0811 plzweig@aol.com or Investor Relations: Douglas W. Cowan, 972/294-1010 rtifinancial@vanishpoint.com EX-99.2 4 dex992.txt 1ST AMEND. TO NAT. MARKETING & DISTRIBUTION AGR. EXHIBIT 99.2 First Amendment to National Marketing and Distribution Agreement ---------------------------------------------------------------- This Amendment is made this 25 day of June, 2001, by and between Retractable Technologies, Inc. ("RTI") and Abbott Laboratories ("Abbott"). RTI and Abbott have previously entered into a National Marketing and Distribution Agreement dated May 4, 2000 (the "Agreement") and now have agreed to amend the Agreement as follows: 1. Add Section 2.9 which shall read as follows: "Trays. With respect to Products purchased by Abbott pursuant to this ----- Agreement, RTI hereby grants Abbott the right to place such Products in spinal and epidural anesthesia trays manufactured and/or marketed by Abbott. The right to place Products in anesthesia trays for marketing and distribution in the Hospital Market shall be exclusive to Abbott." 2. Except as amended hereby, the terms of the Agreement shall remain in full force and effect as originally stated. The parties intending to be bound by this Amendment have caused this Amendment to be signed by their duly authorized representatives on the date first written above. ABBOTT LABORATORIES RETRACTABLE TECHNOLOGIES, INC. By: /s/ Laurie Hernandez By: /s/ Thomas J. Shaw ---------------------- ------------------ Title: General Manager Title: CEO ---------------------- ------------------ -----END PRIVACY-ENHANCED MESSAGE-----